Ubs Asset Management Americas Inc Haemonetics Corp Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 128,123 shares of HAE stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,123
Previous 131,766
2.76%
Holding current value
$10.9 Million
Previous $10.9 Million
5.54%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$506 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$439 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$377 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$357 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$342 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.36B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...